Skip to main content

Advertisement

SpringerLink
Log in

Pancreatic neuroendocrine neoplasms: diagnosis and management

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Pancreatic neuroendocrine neoplasms are uncommon but rising in incidence. There have been recent changes in the WHO nomenclature and a newly proposed American Joint Committee on Cancer TNM staging, which complement each other. These neoplasms are of great medical and radiological interest because of their diverse presenting features and imaging appearances. There is an increased role for both anatomic and functional imaging in the assessment of these neoplasms. A review of the nomenclature, staging, and imaging is presented in this paper.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16
Fig. 17

Similar content being viewed by others

References

  1. Ehehalt F, Saeger HD, Schmidt CM, Grutzmann R (2009) Neuroendocrine tumors of the pancreas. The oncologist 14:456–467

    Article  PubMed  CAS  Google Scholar 

  2. Kloppel G (2011) Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer 18(Suppl 1):S1–S16

    Article  PubMed  Google Scholar 

  3. Metz DC, Jensen RT (2008) Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 135:1469–1492

    Article  PubMed  CAS  Google Scholar 

  4. Yao JC, Hassan M, Phan A, et al. (2008) One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063–3072

    Article  PubMed  Google Scholar 

  5. Kimura W, Kuroda A, Morioka Y (1991) Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci 36:933–942

    Article  PubMed  CAS  Google Scholar 

  6. Oberg K, Eriksson B (2005) Endocrine tumours of the pancreas. Best Pract Res 19:753–781

    Article  Google Scholar 

  7. Zerbi A, Falconi M, Rindi G, et al. (2010) Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases. Am J Gastroenterol 105(6):1421–1429

    Article  PubMed  Google Scholar 

  8. Panzuto F, Nasoni S, Falconi M, et al. (2005) Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 12:1083–1092

    Article  PubMed  Google Scholar 

  9. Falconi M, Plockinger U, Kwekkeboom DJ, et al. (2006) Well-differentiated pancreatic nonfunctioning tumors/carcinoma. Neuroendocrinology 84:196–211

    Article  PubMed  CAS  Google Scholar 

  10. Jensen RT, Berna MJ, Bingham DB, Norton JA (2008) Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 113:1807–1843

    Article  PubMed  Google Scholar 

  11. Lemos MC, Thakker RV (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29:22–32

    Article  PubMed  CAS  Google Scholar 

  12. Pape UF, Berndt U, Muller-Nordhorn J, et al. (2008) Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 15:1083–1097

    Article  PubMed  Google Scholar 

  13. Kuzin NM, Egorov AV, Kondrashin SA, et al. (1998) Preoperative and intraoperative topographic diagnosis of insulinomas. World J Surg 22:593–597 ((discussion 597–598))

    Article  PubMed  CAS  Google Scholar 

  14. Sundin A, Vullierme MP, Kaltsas G, Plockinger U (2009) ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological examinations. Neuroendocrinology 90:167–183

    Article  PubMed  CAS  Google Scholar 

  15. D’Onofrio M, Mansueto G, Vasori S, Falconi M, Procacci C (2003) Contrast-enhanced ultrasonographic detection of small pancreatic insulinoma. J Ultrasound Med 22:413–417

    PubMed  Google Scholar 

  16. D’Onofrio M, Mansueto G, Falconi M, Procacci C (2004) Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. Abdom Imaging 29:246–258

    Article  PubMed  Google Scholar 

  17. Rockall AG, Reznek RH (2007) Imaging of neuroendocrine tumours (CT/MR/US). Best Pract Res Clin Endocrinol Metab 21:43–68

    Article  PubMed  CAS  Google Scholar 

  18. De Angelis C, Carucci P, Repici A, Rizzetto M (1999) Endosonography in decision making and management of gastrointestinal endocrine tumors. Eur J Ultrasound 10:139–150

    Article  PubMed  Google Scholar 

  19. Chiti A, Fanti S, Savelli G, et al. (1998) Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours. Eur J Nucl Med 25:1396–1403

    Article  PubMed  CAS  Google Scholar 

  20. Gorman B, Charboneau JW, James EM, et al. (1986) Benign pancreatic insulinoma: preoperative and intraoperative sonographic localization. AJR 147:929–934

    Article  PubMed  CAS  Google Scholar 

  21. Grover AC, Skarulis M, Alexander HR, et al. (2005) A prospective evaluation of laparoscopic exploration with intraoperative ultrasound as a technique for localizing sporadic insulinomas. Surgery 138:1003–1008 ((discussion 1008))

    Article  PubMed  Google Scholar 

  22. Langer P, Kann PH, Fendrich V, et al. (2004) Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. World J Surg 28:1317–1322

    Article  PubMed  Google Scholar 

  23. Wamsteker EJ, Gauger PG, Thompson NW, Scheiman JM (2003) EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia. Gastrointest Endosc 58:531–535

    Article  PubMed  Google Scholar 

  24. Lonser RR, Glenn GM, Walther M, et al. (2003) von Hippel–Lindau disease. Lancet 361:2059–2067

    Article  PubMed  CAS  Google Scholar 

  25. Gouya H, Vignaux O, Augui J, et al. (2003) CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR 181:987–992

    Article  PubMed  Google Scholar 

  26. Rappeport ED, Hansen CP, Kjaer A, Knigge U (2006) Multidetector computed tomography and neuroendocrine pancreaticoduodenal tumors. Acta Radiol 47:248–256

    Article  PubMed  CAS  Google Scholar 

  27. Boukhman MP, Karam JM, Shaver J, et al. (1999) Localization of insulinomas. Arch Surg 134:818–822 ((discussion 822–813))

    Article  PubMed  CAS  Google Scholar 

  28. Buetow PC, Parrino TV, Buck JL, et al. (1995) Islet cell tumors of the pancreas: pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status. AJR 165:1175–1179

    Article  PubMed  CAS  Google Scholar 

  29. Rodallec M, Vilgrain V, Couvelard A, et al. (2006) Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology 6:77–85

    Article  PubMed  CAS  Google Scholar 

  30. Ahrendt SA, Komorowski RA, Demeure MJ, Wilson SD, Pitt HA (2002) Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible? J Gastrointest Surg 6:66–74

    Article  PubMed  Google Scholar 

  31. Bordeianou L, Vagefi PA, Sahani D, et al. (2008) Cystic pancreatic endocrine neoplasms: a distinct tumor type? J Am Coll Surg 206:1154–1158

    Article  PubMed  Google Scholar 

  32. Bok EJ, Cho KJ, Williams DM, et al. (1984) Venous involvement in islet cell tumors of the pancreas. AJR 142:319–322

    Article  PubMed  CAS  Google Scholar 

  33. Shimizu K, Shiratori K, Toki F, et al. (1999) Nonfunctioning islet cell tumor with a unique pattern of tumor growth. Dig Dis Sci 44:547–551

    Article  PubMed  CAS  Google Scholar 

  34. Kitami CE, Shimizu T, Sato O, et al. (2000) Malignant islet cell tumor projecting into the main pancreatic duct. J Hepatobiliary Pancreat Surg 7:529–533

    Article  PubMed  CAS  Google Scholar 

  35. Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB (2000) Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 214:483–490

    PubMed  CAS  Google Scholar 

  36. Semelka RC, Custodio CM, Cem Balci N, Woosley JT (2000) Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. J Magn Reson Imaging 11:141–148

    Article  PubMed  CAS  Google Scholar 

  37. Dromain C, de Baere T, Baudin E, et al. (2003) MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques. AJR 180:121–128

    Article  PubMed  Google Scholar 

  38. Debray MP, Geoffroy O, Laissy JP, et al. (2001) Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br J Radiol 74:1065–1070

    PubMed  CAS  Google Scholar 

  39. Wang Y, Chen ZE, Yaghmai V, et al. (2011) Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging 33:1071–1079

    Article  PubMed  Google Scholar 

  40. Tamm EP, Kim EE, Ng CS (2007) Imaging of neuroendocrine tumors. Hematol Oncol Clin North Am 21:409–432

    Article  PubMed  Google Scholar 

  41. Kwekkeboom DJ, Krenning EP (2002) Somatostatin receptor imaging. Semin Nuclear Medicine 32:84–91

    Article  Google Scholar 

  42. Binderup T, Knigge U, Loft A, Federspiel B, Kjaer A (2010) 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin Cancer Res 16:978–985

    Article  PubMed  CAS  Google Scholar 

  43. Binderup T, Knigge U, Loft A, et al. (2010) Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET. J Nucl Med 51:704–712

    Article  PubMed  Google Scholar 

  44. Eriksson B, Bergstrom M, Sundin A, et al. (2002) The role of PET in localization of neuroendocrine and adrenocortical tumors. Ann N Y Acad Sci 970:159–169

    Article  PubMed  CAS  Google Scholar 

  45. Orlefors H, Sundin A, Garske U, et al. (2005) Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab 90:3392–3400

    Article  PubMed  CAS  Google Scholar 

  46. Teunissen JJ, Kwekkeboom DJ, Valkema R, Krenning EP (2011) Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours. Endocr Rel Cancer 18(Suppl 1):S27–S51

    Article  CAS  Google Scholar 

  47. Kayani I, Bomanji JB, Groves A, et al. (2008) Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1, Tyr3-octreotate) and 18F-FDG. Cancer 112:2447–2455

    Article  PubMed  Google Scholar 

  48. Grant CS (2005) Insulinoma. Best Pract Res Clin Gastroenterol 19:783–798

    Article  PubMed  CAS  Google Scholar 

  49. Fernandez-Cruz L, Saenz A, Astudillo E, et al. (2002) Outcome of laparoscopic pancreatic surgery: endocrine and nonendocrine tumors. World J Surg 26:1057–1065

    Article  PubMed  CAS  Google Scholar 

  50. Berna MJ, Hoffmann KM, Serrano J, Gibril F, Jensen RT (2006) Serum gastrin in Zollinger–Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. Medicine 85:295–330

    Article  PubMed  CAS  Google Scholar 

  51. Tomassetti P, Migliori M, Lalli S, et al. (2001) Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol 12(Suppl 2):S95–S99

    Article  PubMed  Google Scholar 

  52. Weber HC, Venzon DJ, Lin JT, et al. (1995) Determinants of metastatic rate and survival in patients with Zollinger–Ellison syndrome: a prospective long-term study. Gastroenterology 108:1637–1649

    Article  PubMed  CAS  Google Scholar 

  53. Skogseid B, Eriksson B, Lundqvist G, et al. (1991) Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 73:281–287

    Article  PubMed  CAS  Google Scholar 

  54. Norton JA, Fraker DL, Alexander HR, et al. (1999) Surgery to cure the Zollinger–Ellison syndrome. New England J Med 341:635–644

    Article  CAS  Google Scholar 

  55. Thompson NW, Vinik AI, Eckhauser FE (1989) Microgastrinomas of the duodenum. A cause of failed operations for the Zollinger–Ellison syndrome. Annal Surg 209:396–404

    Article  CAS  Google Scholar 

  56. Norton JA, Alexander HR, Fraker DL, et al. (2004) Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger–Ellison syndrome? Annal Surg 239:617–625 ((discussion 626))

    Article  Google Scholar 

  57. Fraker DL, Norton JA, Alexander HR, Venzon DJ, Jensen RT (1994) Surgery in Zollinger–Ellison syndrome alters the natural history of gastrinoma. Annal Surg 220:320–328 ((discussion 328–330))

    Article  CAS  Google Scholar 

  58. Cadiot G, Vuagnat A, Doukhan I, et al. (1999) Prognostic factors in patients with Zollinger–Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d’Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d’Etude du Syndrome de Zollinger–Ellison (GRESZE). Gastroenterology 116:286–293

    Article  PubMed  CAS  Google Scholar 

  59. Norton JA, Fraker DL, Alexander HR, et al. (2006) Surgery increases survival in patients with gastrinoma. Annal Surg 244:410–419

    Google Scholar 

  60. Ellison EC, Sparks J, Verducci JS, et al. (2006) 50-year appraisal of gastrinoma: recommendations for staging and treatment. J Am Coll Surg 202:897–905

    Article  PubMed  Google Scholar 

  61. Steinmuller T, Kianmanesh R, Falconi M, et al. (2008) Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 87:47–62

    Article  PubMed  Google Scholar 

  62. O’Toole D, Ruszniewski P (2005) Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours. Best Pract Res 19:585–594

    Article  Google Scholar 

  63. Kouvaraki MA, Ajani JA, Hoff P, et al. (2004) Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. J Clin Oncol 22:4762–4771

    Article  PubMed  CAS  Google Scholar 

  64. Nikou GC, Toubanakis C, Nikolaou P, et al. (2005) VIPomas: an update in diagnosis and management in a series of 11 patients. Hepatogastroenterology 52:1259–1265

    PubMed  Google Scholar 

  65. Ghaferi AA, Chojnacki KA, Long WD, Cameron JL, Yeo CJ (2008) Pancreatic VIPomas: subject review and one institutional experience. J Gastrointest Surg 12:382–393

    Article  PubMed  Google Scholar 

  66. Soga J, Yakuwa Y (1998) Vipoma/diarrheogenic syndrome: a statistical evaluation of 241 reported cases. J Exp Clin Cancer Res 17:389–400

    PubMed  CAS  Google Scholar 

  67. van Beek AP, de Haas ER, van Vloten WA, et al. (2004) The glucagonoma syndrome and necrolytic migratory erythema: a clinical review. Eur J Endocrinol 151:531–537

    Article  PubMed  Google Scholar 

  68. Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV (1996) The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine 75:53–63

    Article  PubMed  CAS  Google Scholar 

  69. Bartsch DK, Schilling T, Ramaswamy A, et al. (2000) Management of nonfunctioning islet cell carcinomas. World J Surg 24:1418–1424

    Article  PubMed  CAS  Google Scholar 

  70. Solorzano CC, Lee JE, Pisters PW, et al. (2001) Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery 130:1078–1085

    Article  PubMed  CAS  Google Scholar 

  71. Bloomston M, Muscarella P, Shah MH, et al. (2006) Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreas. J Gastrointest Surg 10:1361–1370

    Article  PubMed  Google Scholar 

  72. Evans DB, Skibber JM, Lee JE, et al. (1993) Nonfunctioning islet cell carcinoma of the pancreas. Surgery 114:1175–1181 ((discussion 1181–1172))

    PubMed  CAS  Google Scholar 

  73. Kulke MH, Stuart K, Earle C (2006) A phase II study of temozolomide and bevacizumab in patients with advance neuroendocrine tumors. J Clin Oncol 24(18S):4044

    Google Scholar 

  74. Kulke MH, Blaszkowsky L, Zhu A (2010) Phase I/II study of everolimus (RAD001) in combination with temozolomide in patients with advanced pancreatic neuroendocrine tumors. Gastrointestinal Cancers Symposium 2010, Orlando, FL, p 223a

  75. Kulke MH, Stuart K, Enzinger PC, et al. (2006) Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. J Clin Oncol 24:401–406

    Article  PubMed  CAS  Google Scholar 

  76. Schnirer II, Yao JC, Ajani JA (2003) Carcinoid—a comprehensive review. Acta oncologica (Stockholm, Sweden) 42:672–692

    Article  Google Scholar 

  77. Rinke A, Muller HH, Schade-Brittinger C, et al. (2009) Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 27:4656–4663

    Article  PubMed  CAS  Google Scholar 

  78. Kulke MH, Lenz HJ, Meropol NJ, et al. (2008) Activity of sunitinib in patients with advanced neuroendocrine tumors. J Clin Oncol 26:3403–3410

    Article  PubMed  CAS  Google Scholar 

  79. Raymond E, Dahan L, Raoul JL, et al. (2011) Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 364:501–513

    Article  PubMed  CAS  Google Scholar 

  80. Phan AT, Yao JC, Fogelman D, et al. (2010) A prospective, multi-institutional phase II study of GW786034 (pazopanib) and depot octreotide in advanced lowgrade neuroendocrine carcinoma. J Clin Oncol 28:301s

    Article  Google Scholar 

  81. Yao JC, Shah MH, Ito T, et al. (2011) Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 364:514–523

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Unit 1473, P.O. Box 301402, Houston, TX, 77030, USA

    Aparna Balachandran, Eric P. Tamm, Priya R. Bhosale, Madhavi Patnana, Raghu Vikram & Chuslip Charnsangavej

  2. Division of Surgical Oncology, University of Texas MD Anderson Cancer Center, Faculty Center, FC 12.2028, 1515 Holcombe Boulevard, Unit 0444, Houston, TX, 77030, USA

    Jason B. Fleming & Matthew H. Katz

Authors
  1. Aparna Balachandran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric P. Tamm
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Priya R. Bhosale
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Madhavi Patnana
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Raghu Vikram
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jason B. Fleming
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Matthew H. Katz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chuslip Charnsangavej
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aparna Balachandran.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balachandran, A., Tamm, E.P., Bhosale, P.R. et al. Pancreatic neuroendocrine neoplasms: diagnosis and management. Abdom Imaging 38, 342–357 (2013). https://doi.org/10.1007/s00261-012-9923-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-012-9923-1

Keywords

Search

Navigation